Semaglutide + Cagrilintide
Novo Nordisk's combination of a GLP-1 agonist with a long-acting amylin analogue, hitting two separate appetite pathways at once and producing greater weight loss in trials than either alone. Still investigational — it is not an approved product.
- Sources carrying it
- 21
- Listings indexed
- 32
- Lowest listed
- $61.00
- Median
- $129.00
- Highest listed
- $379.55
across 5mg → 20mg
Sticker prices in US dollars, across every dosage and pack size (5mg → 20mg) — so the spread includes different quantities, not just different sellers. Prices are the sellers' own listed prices, re-checked periodically rather than tracked daily.
Who lists it & for how much
Members only
The 21 sources that list Semaglutide + Cagrilintide, and what each one charges, are behind the membership. Prices above are the range across every source that lists it — the membership is what tells you which source and for how much, with links and contacts.
Already a member? Sign in
Other peptides indexed
- HCGfrom $2.87
- BPC-157from $12.47
- TB-500from $11.43
- HGHfrom $9.37
- Semaglutidefrom $7.31
- Melanotan IIfrom $18.10
- Tirzepatidefrom $20.00
- GHK-Cufrom $13.27
- NAD+from $15.00
- Retatrutidefrom $36.00
- Ipamorelinfrom $11.99
- IGF-1 LR3from $11.70
Sourcery is an information directory. It does not sell anything and does not handle orders — it indexes what sources publish so they can be compared in one place.